CAND PHARM C. CRISTOFFERSEN AS

3735 SKIEN

Finances

Return on Equity

21,17 %

Current Ratio

2,93

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	239 199 000	215 943 000	208 991 000	181 105 000
Net Income	18 595 000	25 116 000	18 622 000	8 043 000
Total Assets	126 988 000	114 664 000	98 625 000	82 815 000
Total Equity	87 835 000	75 239 000	65 123 000	56 492 000

Income (NOK)	2022	2021	2020	2019
Revenue	239 199 000	215 943 000	208 991 000	181 105 000
Expenditure	216 155 000	195 822 000	191 379 000	171 052 000
Operating Profit	23 045 000	20 121 000	17 612 000	10 052 000
Financial Income	690 000	9 700 000	5 365 000	556 000
Financial Costs	−48 000	209 000	499 000	237 000
Financial Balance	738 000	9 491 000	4 866 000	319 000
Earnings Before Tax	23 783 000	29 612 000	22 478 000	10 372 000
Tax	5 188 000	4 496 000	3 857 000	2 329 000
Net Income	18 595 000	25 116 000	18 622 000	8 043 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	12 329 000	13 321 000	16 977 000	18 284 000
Total Current Assets	114 659 000	101 343 000	81 648 000	64 531 000
Total Assets	126 988 000	114 664 000	98 625 000	82 815 000
Total Retained Equity	85 189 000	72 594 000	62 478 000	53 846 000
Total Equity	87 835 000	75 239 000	65 123 000	56 492 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	39 153 000	39 425 000	33 502 000	26 323 000
Total Equity and Debt	126 988 000	114 664 000	98 625 000	82 815 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	238 729 000	215 298 000	208 603 000	180 384 000
Other Income	471 000	644 000	389 000	721 000
Revenue	239 199 000	215 943 000	208 991 000	181 105 000
Cost of Goods Sold	143 677 000	128 349 000	125 559 000	109 212 000
Salary Costs	42 022 000	38 943 000	36 893 000	33 782 000
Depreciation	3 210 000	3 100 000	3 172 000	3 229 000
Impairment	0	0	0	0
Expenditure	216 155 000	195 822 000	191 379 000	171 052 000
Operating Profit	23 045 000	20 121 000	17 612 000	10 052 000
Financial Income	690 000	9 700 000	5 365 000	556 000
Financial Costs	−48 000	209 000	499 000	237 000
Financial Balance	738 000	9 491 000	4 866 000	319 000
Dividends	6 000 000	11 000 000	6 000 000	0
Net Income	18 595 000	25 116 000	18 622 000	8 043 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	749 000	778 000	779 000	529 000
Real Eastate	3 777 000	3 777 000	3 777 000	3 777 000
Machinery and Plant Facilities	0	0	0	0
Fixtures	7 803 000	8 757 000	8 187 000	9 537 000
Total Tangible Assets	11 580 000	12 534 000	11 964 000	13 313 000
Total Fiancial Fixed Assets	0	9 000	4 234 000	4 442 000
Total Fixed Assets	12 329 000	13 321 000	16 977 000	18 284 000
Stock	45 892 000	40 335 000	35 152 000	37 107 000
Total Investments	6 495 000	6 189 000	2 273 000	0
Cash, Bank	32 029 000	28 471 000	20 269 000	8 505 000
Total Current Assets	114 659 000	101 343 000	81 648 000	64 531 000
Total Assets	126 988 000	114 664 000	98 625 000	82 815 000
Total Equity	87 835 000	75 239 000	65 123 000	56 492 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	11 746 000	12 135 000	8 244 000	10 774 000
Unpaid Taxes	7 420 000	7 882 000	6 971 000	5 004 000
Dividends	6 000 000	11 000 000	6 000 000	0
Other Current Debt	8 730 000	10 813 000	10 179 000	5 722 000
Total Current Debt	39 153 000	39 425 000	33 502 000	26 323 000
Total Equity and Debt	126 988 000	114 664 000	98 625 000	82 815 000

Financial indicators	2022	2021	2020	2019
Return on Equity	21,17 %	33,38 %	28,6 %	14,24 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	9,63 %	9,32 %	8,43 %	5,55 %
Current Ratio	2,93	2,57	2,44	2,45
Quick Ratio	−17,01	−111,37	−49,48	−5,98
Equity Ratio	0,69	0,66	0,66	0,68
Gross Profit Margin	39,93 %	40,56 %	39,92 %	39,7 %